0

Close
 
Upcoming Allied Market Research
2023
Alternate Protein Market

Alternate Protein Market

by Type (Protein Isolates, Protein Concentrates, Hydrolyzed), by Application (Animal Feed, Bakery Confectionary, Supplements, Protein Powders, Beverages, Protein Bars, Others) and by Raw Material (Plants, Algae, Insects, Peas, Cultured Meat, Fermented Products, Whey, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

FB : Food Ingredient
Report Code: A07779
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Alternate Protein Market

Request Now !

Protein is an essential Macro nutrient and is made up of building blocks known as amino acids. According to FAO, an adult requires 0.75 g per kg per day as safe level intake of protein. The protein deficiency and malnutrition has caused many diseases around the globe. Alternate protein or Novel protein alternative is usually the meat and dairy substitutes, which are processed by the various food and healthcare industries and used widely in the market. This source of protein has created a potential market for the vegan and health conscious consumers. The processed non-animal substitutes include tofu/soya bean, Wheat gluten, Mycoproteins, cultured meat, insects, and Alga spirulina. This alternative product has been able to show reduction in stress over the environmental sources and greenhouse gas emissions. Innovations in the food processing industry paves way for improved and better alternative consumable products than other natural products such as meat, egg, fish, and others. Asia-Pacific is growing at the fastest rate in terms of alternate protein market. 

COVID-19 Scenario Analysis: 

Lockdown Scenerio

The lockdown scenario due to COVID-19 has affected every segment of the industry. It has brought many companies to a standstill in terms of production, exports, imports, procurement of raw material and revenue generation. The post-COVID-19 scenario is expected to be in favor of the alternate protein market due to increase in the consumer’s purchasing intention and awareness about the alternate options.

Production Hampered

Lockdown has reduced the production and labor shortage in the industries across the globe. The procurement of raw material especially through exports has been impacted on a larger scale. 

Impaired Supply Chain

The COVID-19 situation has led to shutdown of many retail stores, conventional stores, and supermarkets but the e-commerce is distributing channel that is experiencing during the pandemic.

Regulatory Hurdles

The trade restrictions have caused restrictions on export and import from various countries that serve as the raw material source. 

Top Impacting Factors: Market Scenario Analysis, Trends, Drivers, and Impact Analysis

A new generation of products has influenced the consumer buying behavior. The alternate protein products have proven to be sustainable products. Increase in awareness and health consciousness, ease of digestion, allergy concerns, sustainability, vegan protein, high protein quality, high disposable income, urbanization, and customer curiosity drive the growth of the global alternate protein market. These key drivers have shifted the consumer purchasing habit from animal protein to alternative sources of protein. However, varying raw material prices, expensive production techniques and the varying taste of the product hinder the market growth. Contrarily, overcoming the taste gap between the plant-based alternative and animal-based product is a challenge as well as opportunity for this market. The investments in new technology, launches of new and advanced products, requirement for controlling standards in food safety management, trend of taste enhancing ingredients, legislation, litigation, and regulation present new pathways in the industry.

The global alternate protein market trends are as follows:

New product launches to flourish the market

Producing the meat alternatives in the laboratories has created exponential technical advancements without the use of living animals. They have made innovative strides toward improvement of the quality of the products and overall palatability of them as well. The key players like Nestle, Merit, and Burcon have entered into a joint development agreement for the development of plant protein ingredients and their application in the plant-based food &beverages. This series of products will be manufactured by the use of extraction and purification technology patented by Burcon.  

Surge in usage of product and industrial applications 

Manufacturers have invested significant time and resources for development of new products with different variants and flavors due to varying demands based in the vegan market. Beyond Meat has introduced products like go beyond breakfast, easy-to-cook plant-based patties, classic and spicy sausages, beyond burger, and beyond beef made from plant ingredients.  

The introduction of these variants has brought a new trend in the market and would optimize the protein requirement along with the alluring taste and appearance of the product. In addition, these products are decreasing the consumption of the animal-based products and tapping in the meat market. The companies are also offering protein alternatives in the form of dried powder, which usually has a longer shelf life with reliable food safety. The sources of protein have been diversified and alternatives like peas, isolates, canola, and algae are being used along with the processes like fermentation for the production of alternative protein products. 

Key Benefits of the Report:

  • This study presents the analytical depiction of the global alternate protein industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global alternate protein market share.
  • The current market is quantitatively analyzed to highlight the global alternate protein market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global alternate protein market analysis based on competitive intensity and how the competition will take shape in the coming years. 

Questions Answered in the Alternate Protein Market Research Report:

  • What are the leading market players active in the alternate protein market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?

 Alternate Protein Market Report Highlights

Aspects Details
By Type
  • Protein Isolates
  • Protein Concentrates
  • Hydrolyzed
By Application
  • Animal Feed
  • Bakery & Confectionary
  • Supplements
  • Protein Powders
  • Beverages
  • Protein Bars
  • Others
By Raw Material
  • Plants
  • Algae
  • Insects
  • Peas
  • Cultured Meat
  • Fermented Products
  • Whey
  • Others
By Region
  • North America  (US, Canada)
  • Europe  (Germany, UK, France, Italy, Spain, rest of Europe)
  • Asia-Pacific  (China, Japan, India, Australia, Malaysia, Thailand, Indonesia, rest of Asia-Pacific)
  • LAMEA  (Middle East, Brazil, Mexico, rest of LAMEA)
Key Market Players BlueBio Tech Int., Glanbia plc, Merit Functional Foods, Burcon Nutra Science, AgriProtein, Myco Technology Inc., Entomo Farms, Ingredion Incorporated, Archer Daniels Midland Company, Ynsect, Nestle, R&S Blumos, Now Foods, Protix, Enterra Feed Corporation, Beyond Meat, Roquette Freres, Alga technologies Ltd., Kerry Group, Cargill Incorporated, Solar Foods
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: ALTERNATE PROTEIN MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Protein Isolates

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Protein Concentrates

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Hydrolyzed

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: ALTERNATE PROTEIN MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Animal Feed

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Bakery Confectionary

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Supplements

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Protein Powders

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Beverages

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Protein Bars

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Others

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

  • CHAPTER 6: ALTERNATE PROTEIN MARKET, BY RAW MATERIAL

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Raw Material

    • 6.2. Plants

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Algae

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Insects

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Peas

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Cultured Meat

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

    • 6.7. Fermented Products

      • 6.7.1. Key Market Trends, Growth Factors and Opportunities

      • 6.7.2. Market Size and Forecast, By Region

      • 6.7.3. Market Share Analysis, By Country

    • 6.8. Whey

      • 6.8.1. Key Market Trends, Growth Factors and Opportunities

      • 6.8.2. Market Size and Forecast, By Region

      • 6.8.3. Market Share Analysis, By Country

    • 6.9. Others

      • 6.9.1. Key Market Trends, Growth Factors and Opportunities

      • 6.9.2. Market Size and Forecast, By Region

      • 6.9.3. Market Share Analysis, By Country

  • CHAPTER 7: ALTERNATE PROTEIN MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By Raw Material

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Alternate Protein Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By Raw Material

      • 7.2.7. Canada Alternate Protein Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By Raw Material

      • 7.2.8. Mexico Alternate Protein Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By Raw Material

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By Raw Material

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Alternate Protein Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By Raw Material

      • 7.3.7. Germany Alternate Protein Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By Raw Material

      • 7.3.8. Italy Alternate Protein Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By Raw Material

      • 7.3.9. Spain Alternate Protein Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By Raw Material

      • 7.3.10. UK Alternate Protein Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By Raw Material

      • 7.3.11. Russia Alternate Protein Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By Raw Material

      • 7.3.12. Rest Of Europe Alternate Protein Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By Raw Material

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By Raw Material

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Alternate Protein Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By Raw Material

      • 7.4.7. Japan Alternate Protein Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By Raw Material

      • 7.4.8. India Alternate Protein Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By Raw Material

      • 7.4.9. South Korea Alternate Protein Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By Raw Material

      • 7.4.10. Australia Alternate Protein Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By Raw Material

      • 7.4.11. Thailand Alternate Protein Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By Raw Material

      • 7.4.12. Malaysia Alternate Protein Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By Raw Material

      • 7.4.13. Indonesia Alternate Protein Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By Raw Material

      • 7.4.14. Rest of Asia Pacific Alternate Protein Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By Raw Material

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By Raw Material

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Alternate Protein Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By Raw Material

      • 7.5.7. South Africa Alternate Protein Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By Raw Material

      • 7.5.8. Saudi Arabia Alternate Protein Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By Raw Material

      • 7.5.9. UAE Alternate Protein Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By Raw Material

      • 7.5.10. Argentina Alternate Protein Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By Raw Material

      • 7.5.11. Rest of LAMEA Alternate Protein Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By Raw Material

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Beyond Meat

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. RAndS Blumos

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Cargill Incorporated

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Protix

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Kerry Group

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. AgriProtein

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Entomo Farms

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Archer Daniels Midland Company

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Ingredion Incorporated

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Glanbia Plc

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Roquette Freres

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

    • 9.12. Ynsect

      • 9.12.1. Company Overview

      • 9.12.2. Key Executives

      • 9.12.3. Company Snapshot

      • 9.12.4. Operating Business Segments

      • 9.12.5. Product Portfolio

      • 9.12.6. Business Performance

      • 9.12.7. Key Strategic Moves and Developments

    • 9.13. Enterra Feed Corporation

      • 9.13.1. Company Overview

      • 9.13.2. Key Executives

      • 9.13.3. Company Snapshot

      • 9.13.4. Operating Business Segments

      • 9.13.5. Product Portfolio

      • 9.13.6. Business Performance

      • 9.13.7. Key Strategic Moves and Developments

    • 9.14. Alga Technologies Ltd.

      • 9.14.1. Company Overview

      • 9.14.2. Key Executives

      • 9.14.3. Company Snapshot

      • 9.14.4. Operating Business Segments

      • 9.14.5. Product Portfolio

      • 9.14.6. Business Performance

      • 9.14.7. Key Strategic Moves and Developments

    • 9.15. BlueBio Tech Int.

      • 9.15.1. Company Overview

      • 9.15.2. Key Executives

      • 9.15.3. Company Snapshot

      • 9.15.4. Operating Business Segments

      • 9.15.5. Product Portfolio

      • 9.15.6. Business Performance

      • 9.15.7. Key Strategic Moves and Developments

    • 9.16. Now Foods

      • 9.16.1. Company Overview

      • 9.16.2. Key Executives

      • 9.16.3. Company Snapshot

      • 9.16.4. Operating Business Segments

      • 9.16.5. Product Portfolio

      • 9.16.6. Business Performance

      • 9.16.7. Key Strategic Moves and Developments

    • 9.17. Myco Technology Inc.

      • 9.17.1. Company Overview

      • 9.17.2. Key Executives

      • 9.17.3. Company Snapshot

      • 9.17.4. Operating Business Segments

      • 9.17.5. Product Portfolio

      • 9.17.6. Business Performance

      • 9.17.7. Key Strategic Moves and Developments

    • 9.18. Solar Foods

      • 9.18.1. Company Overview

      • 9.18.2. Key Executives

      • 9.18.3. Company Snapshot

      • 9.18.4. Operating Business Segments

      • 9.18.5. Product Portfolio

      • 9.18.6. Business Performance

      • 9.18.7. Key Strategic Moves and Developments

    • 9.19. Nestle

      • 9.19.1. Company Overview

      • 9.19.2. Key Executives

      • 9.19.3. Company Snapshot

      • 9.19.4. Operating Business Segments

      • 9.19.5. Product Portfolio

      • 9.19.6. Business Performance

      • 9.19.7. Key Strategic Moves and Developments

    • 9.20. Burcon Nutra Science

      • 9.20.1. Company Overview

      • 9.20.2. Key Executives

      • 9.20.3. Company Snapshot

      • 9.20.4. Operating Business Segments

      • 9.20.5. Product Portfolio

      • 9.20.6. Business Performance

      • 9.20.7. Key Strategic Moves and Developments

    • 9.21. Merit Functional Foods

      • 9.21.1. Company Overview

      • 9.21.2. Key Executives

      • 9.21.3. Company Snapshot

      • 9.21.4. Operating Business Segments

      • 9.21.5. Product Portfolio

      • 9.21.6. Business Performance

      • 9.21.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ALTERNATE PROTEIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL ALTERNATE PROTEIN MARKET FOR PROTEIN ISOLATES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL ALTERNATE PROTEIN MARKET FOR PROTEIN CONCENTRATES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL ALTERNATE PROTEIN MARKET FOR HYDROLYZED, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL ALTERNATE PROTEIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL ALTERNATE PROTEIN MARKET FOR ANIMAL FEED, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL ALTERNATE PROTEIN MARKET FOR BAKERY CONFECTIONARY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL ALTERNATE PROTEIN MARKET FOR SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL ALTERNATE PROTEIN MARKET FOR PROTEIN POWDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ALTERNATE PROTEIN MARKET FOR BEVERAGES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL ALTERNATE PROTEIN MARKET FOR PROTEIN BARS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL ALTERNATE PROTEIN MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL ALTERNATE PROTEIN MARKET, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL ALTERNATE PROTEIN MARKET FOR PLANTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL ALTERNATE PROTEIN MARKET FOR ALGAE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL ALTERNATE PROTEIN MARKET FOR INSECTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL ALTERNATE PROTEIN MARKET FOR PEAS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL ALTERNATE PROTEIN MARKET FOR CULTURED MEAT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL ALTERNATE PROTEIN MARKET FOR FERMENTED PRODUCTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL ALTERNATE PROTEIN MARKET FOR WHEY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL ALTERNATE PROTEIN MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL ALTERNATE PROTEIN MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA ALTERNATE PROTEIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 27. U.S. ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. U.S. ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. U.S. ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 30. CANADA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. CANADA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. CANADA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE ALTERNATE PROTEIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 46. ITALY ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. ITALY ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. ITALY ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 49. SPAIN ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. SPAIN ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. SPAIN ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 52. UK ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. UK ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. UK ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 55. RUSSIA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. RUSSIA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. RUSSIA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 58. REST OF EUROPE ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 59. REST OF EUROPE ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. REST OF EUROPE ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 61. ASIA-PACIFIC ALTERNATE PROTEIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 62. ASIA-PACIFIC ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. ASIA-PACIFIC ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. ASIA-PACIFIC ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 65. CHINA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. CHINA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. CHINA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 68. JAPAN ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 69. JAPAN ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 71. INDIA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 72. INDIA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. INDIA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 74. SOUTH KOREA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. SOUTH KOREA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. SOUTH KOREA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 77. AUSTRALIA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 78. AUSTRALIA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. AUSTRALIA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 80. THAILAND ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 81. THAILAND ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 82. THAILAND ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 83. MALAYSIA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. MALAYSIA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 85. MALAYSIA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 86. INDONESIA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 87. INDONESIA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. INDONESIA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 89. REST OF ASIA PACIFIC ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA PACIFIC ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. REST OF ASIA PACIFIC ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 92. LAMEA ALTERNATE PROTEIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 93. LAMEA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 96. BRAZIL ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 97. BRAZIL ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 98. BRAZIL ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 99. SOUTH AFRICA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 100. SOUTH AFRICA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 101. SOUTH AFRICA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 102. SAUDI ARABIA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 103. SAUDI ARABIA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. SAUDI ARABIA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 105. UAE ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 106. UAE ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 107. UAE ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 108. ARGENTINA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 109. ARGENTINA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 110. ARGENTINA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA ALTERNATE PROTEIN, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 112. REST OF LAMEA ALTERNATE PROTEIN, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 113. REST OF LAMEA ALTERNATE PROTEIN, BY RAW MATERIAL, 2022-2032 ($MILLION)
  • TABLE 114. BEYOND MEAT: KEY EXECUTIVES
  • TABLE 115. BEYOND MEAT: COMPANY SNAPSHOT
  • TABLE 116. BEYOND MEAT: OPERATING SEGMENTS
  • TABLE 117. BEYOND MEAT: PRODUCT PORTFOLIO
  • TABLE 118. BEYOND MEAT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. RANDS BLUMOS: KEY EXECUTIVES
  • TABLE 120. RANDS BLUMOS: COMPANY SNAPSHOT
  • TABLE 121. RANDS BLUMOS: OPERATING SEGMENTS
  • TABLE 122. RANDS BLUMOS: PRODUCT PORTFOLIO
  • TABLE 123. RANDS BLUMOS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. CARGILL INCORPORATED: KEY EXECUTIVES
  • TABLE 125. CARGILL INCORPORATED: COMPANY SNAPSHOT
  • TABLE 126. CARGILL INCORPORATED: OPERATING SEGMENTS
  • TABLE 127. CARGILL INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 128. CARGILL INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. PROTIX: KEY EXECUTIVES
  • TABLE 130. PROTIX: COMPANY SNAPSHOT
  • TABLE 131. PROTIX: OPERATING SEGMENTS
  • TABLE 132. PROTIX: PRODUCT PORTFOLIO
  • TABLE 133. PROTIX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. KERRY GROUP: KEY EXECUTIVES
  • TABLE 135. KERRY GROUP: COMPANY SNAPSHOT
  • TABLE 136. KERRY GROUP: OPERATING SEGMENTS
  • TABLE 137. KERRY GROUP: PRODUCT PORTFOLIO
  • TABLE 138. KERRY GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. AGRIPROTEIN: KEY EXECUTIVES
  • TABLE 140. AGRIPROTEIN: COMPANY SNAPSHOT
  • TABLE 141. AGRIPROTEIN: OPERATING SEGMENTS
  • TABLE 142. AGRIPROTEIN: PRODUCT PORTFOLIO
  • TABLE 143. AGRIPROTEIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. ENTOMO FARMS: KEY EXECUTIVES
  • TABLE 145. ENTOMO FARMS: COMPANY SNAPSHOT
  • TABLE 146. ENTOMO FARMS: OPERATING SEGMENTS
  • TABLE 147. ENTOMO FARMS: PRODUCT PORTFOLIO
  • TABLE 148. ENTOMO FARMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. ARCHER DANIELS MIDLAND COMPANY: KEY EXECUTIVES
  • TABLE 150. ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
  • TABLE 151. ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
  • TABLE 152. ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
  • TABLE 153. ARCHER DANIELS MIDLAND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. INGREDION INCORPORATED: KEY EXECUTIVES
  • TABLE 155. INGREDION INCORPORATED: COMPANY SNAPSHOT
  • TABLE 156. INGREDION INCORPORATED: OPERATING SEGMENTS
  • TABLE 157. INGREDION INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 158. INGREDION INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. GLANBIA PLC: KEY EXECUTIVES
  • TABLE 160. GLANBIA PLC: COMPANY SNAPSHOT
  • TABLE 161. GLANBIA PLC: OPERATING SEGMENTS
  • TABLE 162. GLANBIA PLC: PRODUCT PORTFOLIO
  • TABLE 163. GLANBIA PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 164. ROQUETTE FRERES: KEY EXECUTIVES
  • TABLE 165. ROQUETTE FRERES: COMPANY SNAPSHOT
  • TABLE 166. ROQUETTE FRERES: OPERATING SEGMENTS
  • TABLE 167. ROQUETTE FRERES: PRODUCT PORTFOLIO
  • TABLE 168. ROQUETTE FRERES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 169. YNSECT: KEY EXECUTIVES
  • TABLE 170. YNSECT: COMPANY SNAPSHOT
  • TABLE 171. YNSECT: OPERATING SEGMENTS
  • TABLE 172. YNSECT: PRODUCT PORTFOLIO
  • TABLE 173. YNSECT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 174. ENTERRA FEED CORPORATION: KEY EXECUTIVES
  • TABLE 175. ENTERRA FEED CORPORATION: COMPANY SNAPSHOT
  • TABLE 176. ENTERRA FEED CORPORATION: OPERATING SEGMENTS
  • TABLE 177. ENTERRA FEED CORPORATION: PRODUCT PORTFOLIO
  • TABLE 178. ENTERRA FEED CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 179. ALGA TECHNOLOGIES LTD.: KEY EXECUTIVES
  • TABLE 180. ALGA TECHNOLOGIES LTD.: COMPANY SNAPSHOT
  • TABLE 181. ALGA TECHNOLOGIES LTD.: OPERATING SEGMENTS
  • TABLE 182. ALGA TECHNOLOGIES LTD.: PRODUCT PORTFOLIO
  • TABLE 183. ALGA TECHNOLOGIES LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 184. BLUEBIO TECH INT.: KEY EXECUTIVES
  • TABLE 185. BLUEBIO TECH INT.: COMPANY SNAPSHOT
  • TABLE 186. BLUEBIO TECH INT.: OPERATING SEGMENTS
  • TABLE 187. BLUEBIO TECH INT.: PRODUCT PORTFOLIO
  • TABLE 188. BLUEBIO TECH INT.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 189. NOW FOODS: KEY EXECUTIVES
  • TABLE 190. NOW FOODS: COMPANY SNAPSHOT
  • TABLE 191. NOW FOODS: OPERATING SEGMENTS
  • TABLE 192. NOW FOODS: PRODUCT PORTFOLIO
  • TABLE 193. NOW FOODS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 194. MYCO TECHNOLOGY INC.: KEY EXECUTIVES
  • TABLE 195. MYCO TECHNOLOGY INC.: COMPANY SNAPSHOT
  • TABLE 196. MYCO TECHNOLOGY INC.: OPERATING SEGMENTS
  • TABLE 197. MYCO TECHNOLOGY INC.: PRODUCT PORTFOLIO
  • TABLE 198. MYCO TECHNOLOGY INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 199. SOLAR FOODS: KEY EXECUTIVES
  • TABLE 200. SOLAR FOODS: COMPANY SNAPSHOT
  • TABLE 201. SOLAR FOODS: OPERATING SEGMENTS
  • TABLE 202. SOLAR FOODS: PRODUCT PORTFOLIO
  • TABLE 203. SOLAR FOODS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 204. NESTLE: KEY EXECUTIVES
  • TABLE 205. NESTLE: COMPANY SNAPSHOT
  • TABLE 206. NESTLE: OPERATING SEGMENTS
  • TABLE 207. NESTLE: PRODUCT PORTFOLIO
  • TABLE 208. NESTLE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 209. BURCON NUTRA SCIENCE: KEY EXECUTIVES
  • TABLE 210. BURCON NUTRA SCIENCE: COMPANY SNAPSHOT
  • TABLE 211. BURCON NUTRA SCIENCE: OPERATING SEGMENTS
  • TABLE 212. BURCON NUTRA SCIENCE: PRODUCT PORTFOLIO
  • TABLE 213. BURCON NUTRA SCIENCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 214. MERIT FUNCTIONAL FOODS: KEY EXECUTIVES
  • TABLE 215. MERIT FUNCTIONAL FOODS: COMPANY SNAPSHOT
  • TABLE 216. MERIT FUNCTIONAL FOODS: OPERATING SEGMENTS
  • TABLE 217. MERIT FUNCTIONAL FOODS: PRODUCT PORTFOLIO
  • TABLE 218. MERIT FUNCTIONAL FOODS: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ALTERNATE PROTEIN MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ALTERNATE PROTEIN MARKET
  • FIGURE 3. SEGMENTATION ALTERNATE PROTEIN MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ALTERNATE PROTEIN MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALALTERNATE PROTEIN MARKET
  • FIGURE 11. ALTERNATE PROTEIN MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. ALTERNATE PROTEIN MARKET FOR PROTEIN ISOLATES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. ALTERNATE PROTEIN MARKET FOR PROTEIN CONCENTRATES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. ALTERNATE PROTEIN MARKET FOR HYDROLYZED, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. ALTERNATE PROTEIN MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. ALTERNATE PROTEIN MARKET FOR ANIMAL FEED, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. ALTERNATE PROTEIN MARKET FOR BAKERY CONFECTIONARY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. ALTERNATE PROTEIN MARKET FOR SUPPLEMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. ALTERNATE PROTEIN MARKET FOR PROTEIN POWDERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. ALTERNATE PROTEIN MARKET FOR BEVERAGES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. ALTERNATE PROTEIN MARKET FOR PROTEIN BARS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. ALTERNATE PROTEIN MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. ALTERNATE PROTEIN MARKET SEGMENTATION, BY BY RAW MATERIAL
  • FIGURE 24. ALTERNATE PROTEIN MARKET FOR PLANTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. ALTERNATE PROTEIN MARKET FOR ALGAE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. ALTERNATE PROTEIN MARKET FOR INSECTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. ALTERNATE PROTEIN MARKET FOR PEAS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. ALTERNATE PROTEIN MARKET FOR CULTURED MEAT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. ALTERNATE PROTEIN MARKET FOR FERMENTED PRODUCTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. ALTERNATE PROTEIN MARKET FOR WHEY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. ALTERNATE PROTEIN MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 33. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 34. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 35. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 36. COMPETITIVE DASHBOARD
  • FIGURE 37. COMPETITIVE HEATMAP: ALTERNATE PROTEIN MARKET
  • FIGURE 38. Top player positioning, 2022
  • FIGURE 39. BEYOND MEAT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. BEYOND MEAT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. BEYOND MEAT: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. RANDS BLUMOS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. RANDS BLUMOS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. RANDS BLUMOS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. CARGILL INCORPORATED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. CARGILL INCORPORATED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. CARGILL INCORPORATED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. PROTIX: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. PROTIX: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. PROTIX: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. KERRY GROUP: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. KERRY GROUP: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. KERRY GROUP: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. AGRIPROTEIN: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. AGRIPROTEIN: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. AGRIPROTEIN: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. ENTOMO FARMS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. ENTOMO FARMS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. ENTOMO FARMS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. INGREDION INCORPORATED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. INGREDION INCORPORATED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. INGREDION INCORPORATED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 66. GLANBIA PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. GLANBIA PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 68. GLANBIA PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 69. ROQUETTE FRERES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 70. ROQUETTE FRERES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 71. ROQUETTE FRERES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 72. YNSECT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 73. YNSECT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 74. YNSECT: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 75. ENTERRA FEED CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 76. ENTERRA FEED CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 77. ENTERRA FEED CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 78. ALGA TECHNOLOGIES LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 79. ALGA TECHNOLOGIES LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 80. ALGA TECHNOLOGIES LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 81. BLUEBIO TECH INT.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 82. BLUEBIO TECH INT.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 83. BLUEBIO TECH INT.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 84. NOW FOODS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 85. NOW FOODS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 86. NOW FOODS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 87. MYCO TECHNOLOGY INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 88. MYCO TECHNOLOGY INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 89. MYCO TECHNOLOGY INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 90. SOLAR FOODS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 91. SOLAR FOODS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 92. SOLAR FOODS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 93. NESTLE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 94. NESTLE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 95. NESTLE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 96. BURCON NUTRA SCIENCE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 97. BURCON NUTRA SCIENCE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 98. BURCON NUTRA SCIENCE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 99. MERIT FUNCTIONAL FOODS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 100. MERIT FUNCTIONAL FOODS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 101. MERIT FUNCTIONAL FOODS: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Alternate Protein Market

Start reading.
This Report and over 66,983+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers